NEREUS Trademark

Trademark Overview

On Monday, December 15, 2025, a trademark application was filed for NEREUS with the United States Patent and Trademark Office. The USPTO has given the NEREUS trademark a serial number of 99548441. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 21, 2026. This trademark is owned by Vanda Pharmaceuticals Inc.. The NEREUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of nausea in gastroparesis; Pharmaceutical preparations for the treatment of symptoms of gastroparesis; Pharmaceutical preparations for the treatment and prevention of vomiting induced by motion; Pharmaceutical preparations for the treatment of vomiting in gastroparesis; Pharmaceutical preparat...
nereus

General Information

Serial Number99548441
Word MarkNEREUS
Filing DateMonday, December 15, 2025
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 26, 2026

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of nausea in gastroparesis; Pharmaceutical preparations for the treatment of symptoms of gastroparesis; Pharmaceutical preparations for the treatment and prevention of vomiting induced by motion; Pharmaceutical preparations for the treatment of vomiting in gastroparesis; Pharmaceutical preparations for the treatment and prevention of nausea induced by motion

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 15, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVanda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20037
US
Party NameVanda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037
US

Trademark Events

Event DateEvent Description
Monday, December 15, 2025NEW APPLICATION ENTERED
Monday, December 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 15, 2025APPLICATION FILING RECEIPT MAILED
Friday, April 17, 2026ASSIGNED TO EXAMINER
Monday, April 27, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 20, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 26, 2026PUBLISHED FOR OPPOSITION
Tuesday, May 26, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2026NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

nereus pharmaceutical treatment preparations prevention gastroparesis vomiting disorders diseases caused conditions